Kintara Therapeutics Inc. Gains 46.05%
Wed, Mar 13, 2024 at 07:19 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) soared at $0.12, a gain of 46.1%. On Wed, Mar 13, 2024, KTRA:NASDAQ hit a New 2-Week High of $0.12. The stock got featured on our News Catalysts scanner on Wed, Feb 14, 2024 at 06:56 PM in the 'INVESTOR UPDATE' category. From Wed, Feb 28, 2024, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Feb 20, 2024 at $0.14 with a volume of 83M+.
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Laird Superfood Inc. (LSF:NYSEMKT), 104.3%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 61.79%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 59.61%
- Vroom Inc. (VRM:NASDAQ), 53.83%
- Gaxos.ai Inc Com (New) (GXAI:NASDAQ), 51.13%
- Arq Inc (ARQ:NASDAQ), 46.69%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 46.05%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 37.01%
- Li-Cycle Holdings Corp. (LICY:NYSE), 36.26%
- Airship AI Holdings Inc Com (AISP:NASDAQ), 31.63%